Poor prognosis is associated with the loss of stromal Cav1 in the fibroblast of ductal carcinoma in situ (DCIS), gastric cancer, and prostate cancer [10,15,16]. This evidence concerns the gene CAV1 and ductal breast carcinoma in situ.